Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Rectal Neoplasms 1Pain 1Neoplasms 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphedema 1Glioma 1Fallopian Tube Neoplasms 1Carcinoma in Situ 1Brenner Tumor 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Abnormalities, Radiation-Induced 1

Interventions

Paclitaxel 11Carboplatin 7Taxes 5Bevacizumab 5Immunoglobulin G 4Disulfides 4Cisplatin 4paclitaxel poliglumex 1Watchful Waiting 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Observation 1Mitoxantrone 1Methods 1Gemcitabine 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Cyclophosphamide 1Counseling 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Brenner Tumor × Methods × Clear all
NCT00719303 2018-02-19

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

GOG Foundation

Phase 3 Unknown
1,070 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡